IL213589A0 - DIPYRIDO [2,3-d;4-d] PYRROL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
DIPYRIDO [2,3-d;4-d] PYRROL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- IL213589A0 IL213589A0 IL213589A IL21358911A IL213589A0 IL 213589 A0 IL213589 A0 IL 213589A0 IL 213589 A IL213589 A IL 213589A IL 21358911 A IL21358911 A IL 21358911A IL 213589 A0 IL213589 A0 IL 213589A0
- Authority
- IL
- Israel
- Prior art keywords
- dipyrido
- preparation
- pharmaceutical compositions
- compositions containing
- pyrrol derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20302208P | 2008-12-18 | 2008-12-18 | |
PCT/US2009/066534 WO2010080253A1 (en) | 2008-12-18 | 2009-12-03 | Tricyclic azaindoles |
Publications (2)
Publication Number | Publication Date |
---|---|
IL213589A0 true IL213589A0 (en) | 2011-07-31 |
IL213589A IL213589A (en) | 2016-02-29 |
Family
ID=41682740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL213589A IL213589A (en) | 2008-12-18 | 2011-06-16 | Dipyrido [2,3-d;4-d] pyrrol derivatives, their preparation and pharmaceutical compositions containing them |
Country Status (8)
Country | Link |
---|---|
US (1) | US8853391B2 (en) |
EP (1) | EP2367822B1 (en) |
JP (2) | JP2012512871A (en) |
AU (1) | AU2009336040B2 (en) |
CA (1) | CA2745085C (en) |
ES (1) | ES2603208T3 (en) |
IL (1) | IL213589A (en) |
WO (1) | WO2010080253A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2558446T5 (en) | 2010-04-16 | 2019-12-09 | Ac Immune Sa | New compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
KR20150130398A (en) * | 2013-03-14 | 2015-11-23 | 브리스톨-마이어스 스큅 컴퍼니 | Bicyclo [2.2.2] acid gpr120 modulators |
GB201704325D0 (en) * | 2017-03-17 | 2017-05-03 | Argonaut Therapeutics Ltd | Compounds |
CN111757882B (en) * | 2018-01-05 | 2023-08-22 | Ac免疫有限公司 | Compounds for treating, alleviating or preventing conditions associated with tau aggregates |
US10633383B2 (en) | 2018-01-05 | 2020-04-28 | Ac Immune Sa | Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates |
EA202091395A1 (en) * | 2018-06-04 | 2020-10-01 | Ас Иммьюн Са | DERIVATIVES OF 1,3,4,5-TETRAHYDRO-2H-PYRIDO [4,3-b] INDOL FOR TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES SUCH AS ALZHEIMER'S DISEASE |
CN112313230B (en) * | 2018-06-04 | 2024-03-15 | Ac免疫有限公司 | Novel compounds for the treatment, alleviation or prevention of conditions associated with Tau aggregate |
WO2020037155A1 (en) * | 2018-08-16 | 2020-02-20 | Recreo Pharmaceuticals Llc | 1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indole derivative compounds and uses thereof |
CA3131805C (en) | 2019-03-01 | 2023-11-21 | Ac Immune Sa | Novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1268771A (en) * | 1968-03-15 | 1972-03-29 | Glaxo Lab Ltd | Azacarbazoles |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
EP0880508B1 (en) | 1996-02-13 | 2003-04-16 | AstraZeneca AB | Quinazoline derivatives as vegf inhibitors |
ATE211134T1 (en) | 1996-03-05 | 2002-01-15 | 4-ANILINOQUINAZOLINE DERIVATIVES | |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
US6589954B1 (en) * | 1998-05-22 | 2003-07-08 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
KR20030013433A (en) | 2000-05-31 | 2003-02-14 | 아스트라제네카 아베 | Indole derivatives with vascular damaging activity |
AU6623301A (en) | 2000-07-07 | 2002-01-21 | Angiogene Pharm Ltd | Colchinol derivatives as vascular damaging agents |
EE200300015A (en) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as inhibitors of angiogenesis |
US20040014676A1 (en) * | 2001-07-09 | 2004-01-22 | Ramalinga Dharanipragada | SRC kinase inhibitors useful for treating osteoporosis |
FR2891459B1 (en) * | 2005-09-30 | 2007-12-28 | Flamel Technologies Sa | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE INGREDIENT AND ORAL GALENIC FORM COMPRISING THE SAME |
US8119655B2 (en) * | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
EP2049535A1 (en) * | 2006-08-02 | 2009-04-22 | Takeda Pharmaceutical Company Limited | Alpha-carboline derivatives and methods for preparation thereof |
AU2008269513B2 (en) * | 2007-06-26 | 2011-06-16 | Astrazeneca Ab | 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors |
RU2007139634A (en) * | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | NEW THIAZOLE-, TRIAZOLE- OR OXADIAZOLE-CONTAINING TETRACYCLIC COMPOUNDS |
-
2009
- 2009-12-03 EP EP09793373.3A patent/EP2367822B1/en not_active Not-in-force
- 2009-12-03 WO PCT/US2009/066534 patent/WO2010080253A1/en active Application Filing
- 2009-12-03 AU AU2009336040A patent/AU2009336040B2/en not_active Ceased
- 2009-12-03 CA CA2745085A patent/CA2745085C/en not_active Expired - Fee Related
- 2009-12-03 ES ES09793373.3T patent/ES2603208T3/en active Active
- 2009-12-03 JP JP2011542220A patent/JP2012512871A/en active Pending
- 2009-12-03 US US13/140,357 patent/US8853391B2/en not_active Expired - Fee Related
-
2011
- 2011-06-16 IL IL213589A patent/IL213589A/en active IP Right Grant
-
2015
- 2015-06-17 JP JP2015122169A patent/JP6109880B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2745085A1 (en) | 2010-07-15 |
JP2012512871A (en) | 2012-06-07 |
AU2009336040A1 (en) | 2011-06-30 |
US8853391B2 (en) | 2014-10-07 |
AU2009336040B2 (en) | 2015-07-16 |
JP6109880B2 (en) | 2017-04-05 |
JP2015187155A (en) | 2015-10-29 |
US20120022060A1 (en) | 2012-01-26 |
CA2745085C (en) | 2018-03-06 |
IL213589A (en) | 2016-02-29 |
EP2367822A1 (en) | 2011-09-28 |
WO2010080253A1 (en) | 2010-07-15 |
ES2603208T3 (en) | 2017-02-24 |
EP2367822B1 (en) | 2016-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL213589A0 (en) | DIPYRIDO [2,3-d;4-d] PYRROL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
IL213993A (en) | 1,2,3,4-tetrahydropyrido[2,3-b]pyrazine-2-one derivatives and pharmaceutical compositions comprising them | |
IL220432A (en) | Thieno[2,3-b]pyridinedione derivatives and pharmaceutical compositions comprising the same | |
IL200695A (en) | Hydrooxazolo[3,2-a]pyrimidin-7-one derivatives and pharmaceutical compositions comprising the same | |
IL211693A (en) | 3-cyano-6-( amino substituted)-8-( amino optionally substituted)-imidazo[l,2-b]pyridazine derivatives and pharmaceutical compositions comprising them | |
IL193141A (en) | Pyrrolo[2,3-d]pyrimidine-7 -yl-containing sulfamate compounds, pharmaceutical compositions comprising them and uses thereof | |
IL219424A (en) | Imidazo [1,2-b] pyridazine derivatives, combinations, products, pharmaceutical compositions comprising them and process for their preparation and their use as pde10 inhibitors | |
ZA201004823B (en) | Novel pyrazolo [3,4-d]pyrimidine derivatives as anti-cancer agents | |
IL215911A (en) | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives, pharmaceutical compositions comprising them and processes for their preparation and their use in the preparation of medicaments | |
HK1143154A1 (en) | Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors b[23-d] | |
HK1164292A1 (en) | Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same | |
IL215158A (en) | 2,5-disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives, process for their preparation and pharmaceutical compositions comprising them | |
ZA201100429B (en) | Novel imidazo [1,2-a]pyrimidine derivatives,method for the preparation thereof,use thereof as medicaments,pharmaceutical compositions and novel use in particular as met inhibitors | |
IL205189A (en) | 6,7-dihydro-5h-imidazo[1,2-α]imidazole-3-carboxamide derivatives and pharmaceutical compositions comprising them | |
HK1169388A1 (en) | 6,7,8,9-tetrahydro-pyrimido1,2-a pyrimidin-4-one derivatives, their preparation and pharmaceutical use thereof 6789-12-a -4- | |
IL210074A (en) | Process for the preparation of derivatives of pyrido[2,3-d]pyrimidine-7-yl-phenyl | |
IL219371A (en) | Ethynyl-(s-triazolo/pyrazolo)[1,5-a](pyridine/ pyrimidine) derivatives and pharmaceutical compositions comprising them | |
SG10201403138WA (en) | Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof and pharmaceutical use thereof | |
IL212942A (en) | Rifamycin derivatives, process for their preparation, pharmaceutical compositions comprising the same and uses thereof | |
EP2139333A4 (en) | Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators | |
IL206673A0 (en) | Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application | |
ZA200907416B (en) | Pyrimido [4,5-D] azepine derivatives as 5-HT2C agonists | |
IL205710A (en) | Spiro[piperidine-benzopyran] derivatives, pharmaceutical compositions comprising them, process for their preparation and uses thereof | |
EP2139332A4 (en) | Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators | |
IL210377A (en) | Naphthyridone derivatives, their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |